Mylan

Mylan N.V. is an American global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and global headquarters in Canonsburg, Pennsylvania, US. In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, Mylan grew from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world.Mylan went public on the OTC market in February 1973. It is listed on the NASDAQ, and its shares have been a component of NASDAQ Biotechnology, NASDAQ 100, and the S&P 500 indices.The company develops and produces medicines for a wide range of medical disciplines, including oncology, anaphylaxis, antiretrovirals, cardiovascular, respiratory, dermatology, immunology, anesthesia and pain management, infectious disease, gastroenterology, diabetology/endocrinology, and women's healthcare.In 2016, Mylan's pricing of the EpiPen, an epinephrine autoinjector, became controversial and was widely referred to as "price gouging". As a result, investigations were opened into whether Mylan had misclassified the EpiPen under the Medicaid Drug Rebate Program, a common form of pharmaceutical fraud. UpGuard continuously monitors the security posture of Mylan using open-source, commercial, and proprietary threat intelligence feeds. Our analysis is centered on objective, externally verifiable information.

Mylan Security Rating

${grade.letter}
${publicScore}
${cstarScore}
/ 950
Mylan's security rating is based on the analysis of their external attack surface. The higher the rating, the better their security posture. Start a free trial to get a more in-depth risk assessment for Mylan.

Company info

Mylan
Company
Mylan
Employees
Location
CEO
Heather Bresch
Last updated
Last updated
Industries
Last updated today

Mylan Vendor Risk Report

This vendor risk report is based on UpGuard’s continuous monitoring of Mylan's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Last updated today

Mylan Data Breaches, Cybersecurity Incidents and News

Security incidents, news, and data leaks relating to Mylan.

#1 Third Party & Supplier Risk Management Software

See how UpGuard shapes up against other platforms in the market.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating
Want a complete vendor risk report on this company?
Our comprehensive vendor risk report is based on this company's external attack surface and provides actionable insights, industry benchmarking, and historical trends.